Tag: Musculoskeletal
-
Kolling teams driving world-leading research into arthritis care
Posted on:
A Centre for Research Excellence to improve care for inflammatory arthritis will be based at the Kolling following an exciting announcement by Health Minister Greg Hunt. The minister revealed the latest round of National Health and Medical Research Council funding, which will see $2.5 million invested in the centre and its related projects over the
Category:
-
Kolling researchers to lead national project for better back pain care
Posted on:
Researchers from the Kolling Institute will strengthen their expertise in the management of low back pain following a significant funding announcement by the Federal Government. Health minister Greg Hunt revealed the latest round of National Health and Medical Research Investigator Grants, which will see $2.5 million directed to a five-year program of research led by
Category:
-
New fellowship to strengthen commercial research opportunities
Posted on:
Dr Cindy Shu will have a key role in building commercial capabilities at the Kolling after receiving a fellowship from the REDI (Researcher Exchange and Development within Industry) program. The program provides financial support to Australian and international medical technology and pharmaceutical companies to bring the best talent in-house to work on priority medical research
-
Technology to deliver support to those with back pain during the pandemic
Posted on:
While the COVID-19 pandemic is interrupting access to some healthcare services, an innovative approach may hold the key to support for those with low back pain. Researchers at the University of Sydney and the Kolling Institute have launched a study to measure the effectiveness of a mobile health program which offers self-management strategies via text
Category:
-
New technology holds the key to better care for whiplash injuries
Posted on:
New research is set to revolutionise the diagnosis and treatment of whiplash injuries, one of the most common and challenging injuries following a non-catastrophic motor vehicle collision. The longitudinal study, conducted over more than five years, involved researchers from the Kolling Institute along with scientists from Northwestern University, University of Colorado and Stanford University. Close
-
Researchers partner with industry for innovative study into osteoarthritis
Posted on:
Regeneus, a clinical-stage regenerative medicine company, has announced an exciting research collaboration with Professor Christopher Little and the Raymond Purves Bone and Joint Research Laboratory at the Kolling Institute. The study will further explore the disease modifying effects of Progenza™ and assess its effect in modulating the inflammatory and immune responses in a pre-clinical mode
Category:
-
Expertise at the Kolling recognised
Posted on:
Congratulations to Professor David Hunter who’s been announced as a finalist for Research Australia’s annual Health and Medical Research Awards. The prestigious awards celebrate the outstanding achievements of individuals and teams who drive innovative health and medical research. They aim to recognise excellence across the sector, and encourage future generations of researchers. Professor Hunter, the
Category:
-
Research directs spotlight onto the effectiveness of spinal surgery
Posted on:
New research has found that while the majority of Australian spinal surgeons expect large improvements from common spinal procedures, they say there is only poor quality scientific evidence demonstrating the effectiveness of surgery compared with non-surgical approaches like physiotherapy. A team from the Kolling Institute’s Back Pain Research group and the University of Sydney surveyed
Category:
-
International knee transplant study to inform future care
Posted on:
New funding announced by the Federal Government will see researchers from the Kolling Institute and the University of Sydney drive an international study to determine the best treatment for those with knee cartilage damage. More than $1 million dollars has been awarded through a collaborative research grant scheme involving Australia’s National Health and Medical Research
Category:
-
Researchers to identify safer and more effective treatment pathways for rheumatoid and psoriatic arthritis
Posted on:
Kolling researcher Professor Lyn March will lead a large, collaborative national trial to improve treatments and outcomes for those with disabling rheumatoid and psoriatic arthritis. Federal Government MRFF funding will see more than $2.7 million invested in the project which will involve 400 participants across the country. Professor March, who is also the head of
Category: